Background: Childhood asthma is very prevalent and costs can be high, especially in
| INTRODUCTION
Health economic studies are important to support decision-makers in defining health priorities. [1] [2] [3] In the light of the increasing healthcare costs and the consequent threat to the sustainability of healthcare systems, focus should be put in assessing the impact of chronic diseases, aiming to reduce their burden. 4 As one of the most common chronic diseases in childhood, asthma should have reliable economic data available. In childhood asthma, important direct costs (diagnostic tests, medications, medical visits, hospitalizations or emergency admissions) and indirect costs (mainly caregivers' loss of work days and transportation to healthcare services) are relevant and can be high, especially in severe disease. 5 In 2002, Druss et al 6 have quoted asthma as the 13th most expensive medical condition in the USA. In 2011, Barnett and Nurmagambetov used a regression-based method to estimate $56 billions of incremental costs in all-age asthmatic USA population, with a mean value of $3259 per person/y. 7 In the same year, Bravo et al 5 estimated
the cost of asthma in children younger than 15 years old, in Spain, to be €532 million (€1149 person/y). In the same study, the costs within each category of asthma severity ranged from €403 for the mildest to €5930 for the most severe (costs person/y). Even though other asthma economic studies have been conducted, there are few population-based and comprehensive paediatric cost-of-illness studies. 8 This study aimed to estimate the cost of childhood asthma in Portugal. Secondary aims were (i) to describe direct and indirect costs,
(ii) to determine factors associated with costs and (iii) to assess costs according to the level of asthma control.
| METHODS

| Study design and setting
The Cost of Childhood Asthma in Portugal (CASCA project) was a Portuguese, nationwide, population-and prevalence-based, costof-illness study with a societal perspective. This project was reviewed and approved by the Ethics Committee of Centro Hospitalar de São João, Porto, Portugal. Informed consent was obtained from parent (s) or legal guardian(s).
| Participants and data collection
Data from participants of two studies (INAsma and CED2013) were analysed. INAsma was a nationwide survey, from the general population, applied by telephone interview to individuals living in Portugal, in 2010. 9, 10 CED2013 was a population-based survey applied to children attending primary public schools in a Portuguese city (Guimarães), in 2013. Questionnaires were similar in the both studies; however, data on diagnostic tests use were only available in the CED2013 study (questions used are presented in Table S1 ). When the selected participant was younger than 15 years old, the respondent was the usual and most knowledgeable caregiver. For the CASCA project, we included 208 children with current asthma (CA): 98 (0-17 years old) from the INAsma Study and 110 (5-12 years old) from the CED2013 Study (Fig. S1 ). Participants and data collection are further described in supplementary material.
Data collection of prices of healthcare services, diagnostic tests, medication, holding chambers, absenteeism, transportation and subsidies were performed in different sources and databases as described below and in supplementary material.
| Cost estimation methods
Direct healthcare costs of childhood asthma were estimated using a bottom-up approach (person-based Table S3 ).
Indirect costs of childhood asthma were estimated using the human capital method. The cost domains included in indirect costs were as follows: (i) absenteeism, (ii) transportation and (iii) subsidies because of asthma. Databases and reports from the National Statistics Institute (Instituto Nacional de Estatística) 15 and the Ministry of Social Security 16, 17 were used to achieve unitary costs. 
| Definitions
Current asthma was defined as children that "ever had asthma" plus at least one of the following: wheezing, awakening with breathlessness or having an asthma attack in the previous 12 months, or taking asthma medication at the time of the interview. Asthma control was defined according to GINA 14 and categorized into "controlled,"
"partially controlled" and "uncontrolled". Definitions for other variables are described in supplementary material.
| Statistical analysis
Statistical analysis was performed using SPSS version 23 (SPSS IBM, New York, NY, USA). General characteristics of the included participants were described using absolute and relative frequencies. The factors associated with costs of childhood asthma and, specifically, differences in levels of asthma control, were assessed using mixed Poisson-gamma models. A P-value of <.05 was considered statistically significant.
We additionally used decision analytic modelling to perform univariate and multivariate deterministic sensitivity analysis, in order to evaluate how the uncertainty would impact the estimates of national annualized costs of childhood asthma in Portugal. Univariate deterministic sensitivity analysis was performed with the 95% CI of the proportion estimates of occurrence of each item in Portuguese population. The multivariate deterministic sensitivity analysis was set with two case scenarios. The best-/worst-case scenario were set, respectively, with the lower/upper limit of the 95% CI of CA prevalence in Portuguese children; scenario of minimum/maximum use of asthma medications (Table S3) ; and the lower/upper limit of the 95% CI for the proportion of occurrence of each item in Portuguese population.
| RESULTS
Characteristics of the children included in cost-of-illness analysis are summarized in Table S4 . Estimates of mean annualized costs for each cost domain are presented in Table 1 (in Table S5 are presented the mean costs estimated for each of the two primary studies used in the analysis 
| Factors associated with costs of asthma
We observed significant crude associations between total annualized costs of childhood asthma and nocturnal symptoms, asthma attacks and level of asthma control (Table 2) . However, only asthma attacks and level of asthma control had significant and independent associations with total annualized costs of childhood asthma in the final multivariate model adjusted for age.
Children with asthma attacks in the previous 12 months had higher costs than those without asthma attacks (adjusted exponential model Figure 1 ; Table S6 ). Total costs and direct costs, specifically healthcare services use by acute asthma care and diagnostic tests domains, were significantly higher in children with uncontrolled asthma (Figure 2 ).
Scheduled medical visits, treatment or indirect costs were not different between asthma control groups.
| Sensitivity analysis
The univariate deterministic sensitivity analysis is presented in supplementary material (Table S7 ). The multivariate deterministic sensitivity analysis is presented in Table 3 . The mean cost estimates per child with asthma varied between −35% and +53% for total costs, between −36
and +63% for direct costs and between −30 and +23% for indirect costs.
| DISCUSSION
We conducted a cost-of-illness analysis on Portuguese childhood asthma, with a prevalence-based, societal perspective that allowed a broad economic analysis of the disease. We adopted a societal perspective, the most comprehensive approach, because it uses the direct and indirect costs for all members of the society. 20 From a societal perspective, childhood asthma in Portugal costs over €150 million per year, corresponding to more than €900 
| Total, direct and indirect costs of childhood asthma
The cost estimates for childhood asthma in Portugal were slightly The definition of medical costs was similar to our definition of direct costs, and the results were also similar (assuming a 1.23 exchange rate of dollar to euro, in 2006). Non-medical costs included transportation (not absenteeism), but were mainly driven by non-allergic household measures ($710) like air filters, special vacuum cleaners or anti-allergic bed covers that we did not assess in our study, as the current guidelines do not recommend them.
14 T A B L E 1 Annualized costs (in euros) of childhood asthma in Portugal: total costs, mean cost per child with current asthma (CA) and percentage of total costs for each domain/variable Each cost item was calculated for each participant by multiplying the parent/self-reported amount of resources used by the unitary costs of the resources. Costs were indexed to 2010 Portuguese prices in euros.
a Total costs were extrapolated to total Portuguese children with CA (n = 173 681). Previously published studies reported proportions of direct costs between 61% and 88%. 8 Healthcare services use in the context of asthma worsening (non-scheduled medical visits, emergency and hospitalizations) were, altogether, 30% of the total costs of childhood asthma in Portugal. Reducing acute asthma care costs should be one of the major targets for potential savings. Also, by reducing it, other domains (eg, indirect costs) could also be lowered as poorly controlled asthma is associated with higher unscheduled medical visits and higher costs of lost work. 10, 23 Indirect costs were one-fourth of the costs in childhood asthma.
Other studies showed that indirect costs can be as high as 50%. 8 The lack of assessment of costs related to presenteeism and lower salaries in Portugal may justify our proportion of indirect costs. Nevertheless, more than 13 million euros were spent yearly with parental absenteeism T A B L E 2 Factors associated with annualized total costs of childhood asthma in Portugal because of childhood asthma. This value can represent a potential higher burden to society, as loss of parental work can further impact the overall economy.
| Determinants of cost variation in childhood asthma
The most important determinants for higher costs were asthma attacks in the previous 12 months (1.6-fold) and having uncontrolled asthma (2.3-fold). Direct costs were significantly higher in children with uncontrolled asthma, specifically acute asthma care and diagnostic test use. Interestingly, there were no significant differences in costs of scheduled medical visits and treatment for controlled vs uncontrolled children.
Considering a hypothetic scenario (data not shown) in which all
Portuguese children with asthma were controlled, the savings would be more than 30 000 000 € per year (20% reduction). As previously reported, children with not controlled asthma had significantly more unscheduled medical visits and hospitalizations; 10, 24 knowing that uncontrolled asthma is, also, the major determinant for higher costs, effective policies should be directed to improve asthma control and reduce acute care medical visits. Other studies showed that asthma plans/interventions can reduce symptoms, reduce healthcare services use and be cost-effective. 25, 26 Future studies should be designed to have multinational cost-ofillness data, aiming to understand differences between asthma care
and to compare outcomes. Quality-of-life assessment in childhood 
| Strengths and limitations
This was the first Portuguese nationwide, population-based study on costs of childhood asthma. The cost domains analysed allowed us to create a comprehensive picture of childhood asthma costs in Portugal, as did the prevalence-based analysis and societal perspective. We performed a univariate and multivariate deterministic sensitivity analysis, aiming to understand different variations according to uncertainty. Sensitivity analysis is crucial to highlight variability, to make comparisons with other data, and is recommended in economic studies, 27, 28 but this was the first cost-of-illness study on childhood asthma to report a thorough sensitivity analysis for each cost domain.
There were some limitations regarding the data collection, participants and reported outcomes used for cost estimations. There are no validated questionnaires for cost-burden analysis in asthma, 29 yet we used simple direct questions similar to other studies. 8 Participants were derived from INAsma (national sample) and CED2013 (one city sample); school-age children may be overrepresented in our sample; nevertheless, this is the age group with the higher prevalence of asthma in our country. 9 Also, differences in cost estimations between the two studies were only seen in the domain of "treatment"
and total costs were not significantly different (Table S5) . Data on diagnostic tests use were only available in the CED2013 study and then extrapolated for the entire sample. The assumptions made in T A B L E 3 Multivariate deterministic sensitivity analysis-annualized total costs extrapolated to total Portuguese children with current asthma (CA) and mean costs per patient Best-case scenario was set with the lower limit of the 95% CI of CA prevalence in Portuguese children; scenario of minimum use of asthma medications; and the lower limit of the 95% CI for the proportion of occurrence of each variable in Portuguese population. b Worst-case scenario was set with the upper limit of the 95% CI of CA prevalence in Portuguese children; scenario of maximum use of asthma medications;
and the upper limit of the 95% CI for the proportion of occurrence of each variable in Portuguese population.
the treatment domain may also have masked higher cost differences between asthma control groups. Specifically, medication costs were based on the reported medicines used in the previous year, but we were unable to assess the number of doses taken by each participant;
we used a clinical consensus approach for the number of doses of controller and reliever medication, based on GINA guidelines and on conservative estimations of adherence. In transportation, we used an official Portuguese price by kilometre; however, we could not assess how many of the patients used public transports or ambulances. The absenteeism costs were not based on the reported income, but rather on a mean Portuguese daily income according to the parents' professional occupation, which could possibly underestimate the costs of absenteeism. Also, we could not assess parents' presenteeism because of child's asthma.
In conclusion, childhood asthma in Portugal costs €161 410 007.61
per year, corresponding to €929.35 per child with CA. The total cost estimate of childhood asthma corresponds to 0.91% of the Portuguese expenses in health in 2010. Direct costs were three-fourth of total costs, mainly related to acute asthma care (non-scheduled visits, emergency and hospitalizations). The most important factors determining higher costs were asthma attacks in the previous 12 months (1.6-fold) and uncontrolled asthma (2.3-fold). A better asthma control, with a consequent reduction in the acute use of healthcare services, should be the major target for potential savings in this disease.
